Week 2 Flashcards

1
Q

Central Nervous System (CNS)

A
  • Brain

- Spinal cord

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Peripheral Nervous System (PNS)

A

-All nervous tissue outside the CNS including sensory and motor neurons

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Basic functions of the Nervous System

A

-Recognize, processing, and reacting to changes in the internal and external environment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Adrenergic response

A
  • Activated under stress
  • Fight or flight response
  • Ready the body for an immediate response to a potential threat
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Cholinergic response

A
  • Activated under non-stressful conditions
  • Rest-and-digest
  • Digestive process promoted: heart rate and blood pressure decline
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Autonomic Nervous System: Sympathetic and Parasympathetic Divisions

A
  • Produce opposite effects
  • Body tries to maintain proper balance of the two (homeostasis)
  • Don’t always produce opposite effects
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Synapse

A
  • Juncture of neurons

- Includes a pre and post ganglionic neuron

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

5 Mechanisms by which drugs can affect synaptic transmission

A
  • Affect the synthesis of the neurotransmitter in the pre-synaptic nerve
  • Prevent storage of the neurotransmitter in the vesicles within the pre-synaptic nerve
  • Influence release of the neurotransmitter from the pre-synaptic nerve
  • Prevent the normal destruction or repute of the neurotransmitter
  • Bind to the receptor site on the postsynaptic target tissue
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Primary Neurotransmitters of the Autonomic Nervous System

A
  • Norepinephrine

- Acetylcholine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Norepinephrine

A
  • Released by most postganglionic nerves
  • Class of agents called catecholamines
  • Adrenergic receptors
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Acetylcholine

A
  • Released by cholinergic nerves

- 2 types: Muscarinic and Nicotinic receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Norepinephrine is synthesized…..

A
  • In the nerve terminal
  • Requires amino acid phenylalanine and tyrosine
  • Can be renewed, recycled, and reused
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Acetylcholine is synthesized…..

A
  • In persynaptic nerve terminal from choline and coenzyme A

- In the synaptic cleft is rapidly destroyed by acetycholinesterase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Cholinergic receptors of Ach

A
  • Nicotinic

- Muscarinic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Nicotinic

A
  • In sympathetic and parasympathetic divisions

- -Stimulate smooth muscle and gland secretion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Muscarinic

A
  • In parasympathetic target organs except the heart

- Stimulates smooth muscle and gland secretions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

2 types of Adrenergic receptors

A
  • Alpha

- Beta

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Seizures

A
  • Abnormal or uncontrolled neuronal discharges in the brain
  • Affects consciousness, motor activity, sensation
  • Treated with Anti Epileptic Drugs (AED)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Known causes of seizures

A
  • Infectious disease
  • trauma
  • metabolic disorders
  • vascular diseases
  • pediatric disorders
  • neoplastic disease
  • medications
  • high dose of local anesthetics
  • eclampsia
  • drug abuse
  • withdrawal syndromes
  • sedative-hypnotic drugs
20
Q

Epilepsy

A
  • Seizures occurring chronically

- Types: partial (focal), generalized, special epileptic syndromes

21
Q

Simple Partial Seizures

A
  • Olfactory, auditory, and visual hallucinations
  • Intense emotions
  • Twitching of arms, legs, and face
22
Q

Complex Partial (psychomotor) seizures

A
  • Aura (preceding)
  • Brief period of confusion or sleepiness afterward with no memory of seizure (postictal confusion)
  • Fumbling with or attempting to remove clothing
  • No response to verbal commands
23
Q

Absence seizures

A
  • Lasting a few seconds
  • Seen most often in children
  • Misdiagnosed often (especially in children) as ADD or daydreaming
24
Q

Tonic-Clonic seizures (Grand mal)

A
  • Preceded by aura
  • Intense muscle contraction (tonic phase) followed by alternating contraction and relaxation of muscles (clonic phase)
  • Crying at beginning as air leaves lungs; loss of bowel and bladder control; shallow breathing with periods of apnea; usually lasting 1-2 min
  • Disorientation and deep sleep after seizure (postictal state)
  • May become cyanotic in the face
25
Febrile seizure
- Tonic-clonic activity lasting 1-2 min - Rapid return to consciousness - Occurs in children usually between 3 months and 5 yrs of age - Usually benign
26
Myoclonic seizures
- Large jerking movements of a major muscle group, such as an arm - Falling from a sitting position or dropping what is held
27
Status Epilepticus
- Considered a medical emergency | - Continuous seizure activity, which can lead to coma and death
28
The choice of a seizure drop depends upon
- Type of seizure - Patient's hx - Associated pathologies
29
The main FDA warning with anti seizure medications is
-They double the risk of suicidal behavior and ideation
30
When taking phenytoin (Dilantin), what is a common teaching point with oral care
-Brush with a soft bristle toothbrush
31
Effective pharmacotherapy depends on
- Assessment of the degree of pain | - Determining the underlying disorders
32
Substance P
- Neurotransmitter | - Passes on pain message
33
Opioids
- A natural or synthetic morphine-like substance responsible for reducing moderate to severe pain - Receptors: mu, kappa, sigma, delta, epsilon - For pain management mu and kappa receptors are most important
34
What are important considerations when administering pain medication
-Degree of pain and underlying disorders
35
Malignant Hyperthermia
- Fast rise in temperature with severe muscle contractions when succinylcholine is administered - Dantrolene Sodium is the preferred tx (muscle relaxant specific for malignant hyperthermia)
36
Alzheimer's Disease
- Most common degenerative disease of CNS - Progressive loss of brain function, memory loss, confusion, dementia - Etiology unknown - Acetylcholine function affected
37
Parkinson's Disease
- 2nd most common CNS disease - Progressive loss of dopamine, tremor, muscle rigidity, abnormal movement and posture - Fall risk
38
Amyotrophic Lateral Sclerosis (Lou garricks) Disease
-Progressive weakness and wasting of muscles, destruction of motor neurons
39
Multiple Sclerosis
- Demyelination of neurons in the CNS - Progressive weakness, visual disturbances, mood alterations, cognitive deficits - No cure, tx aimed at providing relief from recurring symptoms
40
Huntington's Chorea
-Autosomal dominant genetic disorder, progressive dementia, involuntary spasmodic movements, muscles of limbs and face affected
41
Tx for Parkinson's
- Pharmacotherapy doesn't cure the disorder, but attempts to reduce symptoms - Drug action: restore dopamine function or stimulate dopamine receptors in the brain - Types of drugs: Dopaminergic (Levodopa) & anticholinergics (Benadryl)
42
Tx for Alzheimer's
- Supportive tx of symptoms | - Drugs
43
Tonic spasm
-single, prolonged contraction
44
Clonic spasm
-rapidly, repeated contraction
45
Spasticity
- muscle stays in continual state of contraction | - Usually due to CNS damage
46
Causes for muscle spasms
- Excess use or local injury to skeletal muscle - Overmedication with antipsychotics - Epilepsy - Hypocalcemia pain - Neurologic disorders
47
Pharmacological tx of muscle spasms
- Centrally acting skeletal muscle relaxant - Direct-acting antispasmodics - Neuromuscular blockers